Zaza Iakobishvili

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley et al. · Annals of Oncology · 2020 · 950 citations · Full text

Oncology, Cardiovascular Disease, Cardiac Disease +11

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 717 citations · Full text

Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

Jelena Čelutkienė, Radek Pudil, Teresa López‐Fernández et al. · European Journal of Heart Failure · 2020 · 349 citations · Full text

Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology

Radek Pudil, Christian Mueller, Jelena Čelutkienė et al. · European Journal of Heart Failure · 2020 · 325 citations · Full text

Type-II Myocardial Infarction – Patient Characteristics, Management and Outcomes

Gideon Y. Stein, Gabriel Herscovici, Roman Korenfeld et al. · PLoS ONE · 2014 · 160 citations · Full text